Penelope M. Webb

Articles in Scholarly Journals [Incomplete List]

  1. Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer
    International Journal of Cancer, vol. 122, no. 1, pp. 170–176, 2007
  2. Ovarian cancer survival and polymorphisms in hormone and DNA repair pathway genes
    Cancer Letters, vol. 251, no. 1, pp. 96–104, 2007
  3. The role of glutathione-S-transferase polymorphisms in ovarian cancer survival
    European Journal of Cancer, vol. 43, no. 2, pp. 283–290, 2007
  4. Obesity and the risk of epithelial ovarian cancer: A systematic review and meta-analysis
    European Journal of Cancer, vol. 43, no. 4, pp. 690–709, 2007
  5. Health effects of recreational exposure to Moreton Bay, Australia waters during a Lyngbya majuscula bloom
    Environment International, vol. 33, no. 3, pp. 309–314, 2007
  6. Risk factors for benign, borderline and invasive mucinous ovarian tumors: Epidemiological evidence of a neoplastic continuum?
    Gynecologic Oncology, vol. 107, no. 2, pp. 223–230, 2007
  7. Genome-wide association study identifies novel breast cancer susceptibility loci
    Nature, vol. 447, no. 7148, Article ID nature05887, 6 pages, 2007
  8. Tagging Single Nucleotide Polymorphisms in Cell Cycle Control Genes and Susceptibility to Invasive Epithelial Ovarian Cancer
    Cancer Research, vol. 67, no. 7, pp. 3027–3035, 2007
  9. Microarrays and Epidemiology: Not the Beginning of the End but the End of the Beginning...
    Cancer Epidemiology Biomarkers & Prevention, vol. 16, no. 4, pp. 637–638, 2007
  10. BMC Public Health, vol. 6, no. 1, p. 93, 2006
  11. BMC Dermatology, vol. 6, no. 1, p. 6, 2006
  12. Environmental Health: A Global Access Science Source, vol. 5, no. 1, p. 6, 2006
  13. Novel Variants in Growth Differentiation Factor 9 in Mothers of Dizygotic Twins
    Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 11, pp. 4713–4716, 2006
  14. Cigarette Smoking and Survival after Ovarian Cancer Diagnosis
    Cancer Epidemiology Biomarkers & Prevention, vol. 15, no. 12, pp. 2557–2560, 2006
  15. Stool antigen testing for the diagnosis and confirmation of eradication of Helicobacter pylori infection
    Internal Medicine Journal, vol. 36, no. 2, pp. 139–141, 2006
  16. Expression profiling correlates with treatment response in women with advanced serous epithelial ovarian cancer
    International Journal of Cancer, vol. 119, no. 4, pp. 875–883, 2006
  17. Does smoking increase risk of ovarian cancer? A systematic review
    Gynecologic Oncology, vol. 103, no. 3, pp. 1122–1129, 2006
  18. Benign Epithelial Ovarian Tumours—cancer Precursors or Markers for Ovarian Cancer Risk?
    Cancer Causes & Control, vol. 17, no. 5, pp. 623–632, 2006
  19. Commentary: Weight gain, weight loss, and endometrial cancer
    International Journal of Epidemiology, vol. 35, no. 1, pp. 166–168, 2005
  20. Mathematical Models of Ovarian Cancer Incidence
    Epidemiology, vol. 16, no. 4, pp. 508–515, 2005
  21. Double-Strand Break Repair Gene Polymorphisms and Risk of Breast or Ovarian Cancer
    Cancer Epidemiology Biomarkers & Prevention, vol. 14, no. 2, pp. 319–323, 2005
  22. Height, Age at Menarche, and Risk of Epithelial Ovarian Cancer
    Cancer Epidemiology Biomarkers & Prevention, vol. 14, no. 8, pp. 2045–2048, 2005
  23. Interactions among Smoking, Obesity, and Symptoms of Acid Reflux in Barrett's Esophagus
    Cancer Epidemiology Biomarkers & Prevention, vol. 14, no. 11, pp. 2481–2486, 2005
  24. Coffee, Tea and Caffeine and Risk of Epithelial Ovarian Cancer
    Cancer Causes & Control, vol. 15, no. 4, pp. 359–365, 2004
  25. Effects of Helicobacter pylori eradication among adults with intellectual disability
    Journal of Intellectual Disability Research, vol. 48, no. 7, pp. 646–654, 2004
  26. Recurrence of Helicobacter pylori infection in adults with intellectual disability
    Internal Medicine Journal, vol. 34, no. 3, pp. 132–133, 2004
  27. Changes in survival after breast cancer: improvements in diagnosis or treatment?
    The Breast, vol. 13, no. 1, pp. 7–14, 2004
  28. Symptoms and diagnosis of borderline, early and advanced epithelial ovarian cancer
    Gynecologic Oncology, vol. 92, no. 1, pp. 232–239, 2004
  29. The Different Etiologies of Mucinous and Nonmucinous Epithelial Ovarian Cancers
    Gynecologic Oncology, vol. 88, no. 1, pp. S145–S148, 2003
  30. Ovulation and risk of epithelial ovarian cancer
    International Journal of Cancer, vol. 104, no. 2, pp. 228–232, 2003
  31. Dietary influences on survival after ovarian cancer
    International Journal of Cancer, vol. 106, no. 2, pp. 264–269, 2003
  32. Diagnosis of Helicobacter pylori Infection in Adults with Intellectual Disability
    Journal of Clinical Microbiology, vol. 41, no. 10, pp. 4700–4704, 2003
  33. Family history of breast cancer, age and benign breast disease
    International Journal of Cancer, vol. 100, no. 3, pp. 375–378, 2002
  34. Environmental, medical, behavioural and disability factors associated with Helicobacter pylori infection in adults with intellectual disability
    Journal of Intellectual Disability Research, vol. 46, no. 1, pp. 51–60, 2002
  35. Reproduction-related Risk Factors for Mucinous and Nonmucinous Epithelial Ovarian Cancer
    American Journal of Epidemiology, vol. 153, no. 9, pp. 860–864, 2001
  36. Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype
    Carcinogenesis, vol. 22, no. 1, pp. 67–72, 2001
  37. No significant association between progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of ovarian cancer
    Carcinogenesis, vol. 22, no. 5, pp. 717–721, 2001
  38. Cancer Causes and Control, vol. 12, no. 8, pp. 713–719, 2001
  39. Cancer Causes and Control, vol. 12, no. 9, pp. 855–863, 2001
  40. The microsomal epoxide hydrolase Tyr113His polymorphism: Association with risk of ovarian cancer
    Molecular Carcinogenesis, vol. 30, no. 1, pp. 71–78, 2001
  41. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts
    Gut, vol. 49, no. 3, pp. 347–353, 2001
  42. The toxins of Lyngbya majuscula and their human and ecological health effects
    Environment International, vol. 27, no. 5, pp. 381–392, 2001
  43. CYP17 promotor polymorphism and ovarian cancer risk
    International Journal of Cancer, vol. 86, no. 3, pp. 436–439, 2000
  44. Androgen receptor exon 1 cag repeat length and risk of ovarian cancer
    International Journal of Cancer, vol. 87, no. 5, pp. 637–643, 2000
  45. Cancer Causes and Control, vol. 9, no. 6, pp. 637–644, 1998
  46. Gastric cancer, gastritis and plasma vitamin C: Results from an international correlation and cross-sectional study
    International Journal of Cancer, vol. 73, no. 5, pp. 684–689, 1997
  47. An apparent lack of association betweenHelicobacter pylori infection and risk of gastric cancer in China
    International Journal of Cancer, vol. 67, no. 5, pp. 603–607, 1996
  48. Is Helicobacter pylori Transmitted from Cats to Humans?
    Helicobacter, vol. 1, no. 2, pp. 79–81, 1996
  49. 9 Helicobacter pylori as a risk factor for cancer
    Bailli�re?s Clinical Gastroenterology, vol. 9, no. 3, pp. 563–582, 1995
  50. H pylori and gastric cancer
    The Lancet, vol. 343, no. 8891, pp. 243–244, 1994
  51. Helicobacter pylori infection.
    Gut, vol. 35, no. 5, pp. 716–717, 1994